Edward Wirth, Chief Medical Officer at Asterias Biotherapeutics, Inc. (AST), sold 2,880 shares at $6.00 ($17K) on 2015-09-15, disclosed to the SEC on 2015-09-16.
Scheduled sale ($17k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AST | SELL | 2016-11-21 | $13K | — | Filing → |
| AST | SELL | 2016-10-11 | $28K | — | Filing → |
| AST | SELL | 2016-09-12 | $52K | — | Filing → |